泽泻汤合丹参饮治疗动脉粥样硬化的药理实验及分子生物学作用机制
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(82204668);河北省自然科学基金面上项目(H2020423028);河北省高等学校科学研究计划重点项目(ZD2021079)


Pharmacological Experiment and Molecular Biological Mechanism of Zexie Decoction and Danshen Decoction in Treatment of Atherosclerosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:利用网络药理学技术和动物实验验证探讨泽泻汤合丹参饮治疗动脉粥样硬化(AS)的作用机制。方法:通过中药系统药理学数据库与分析平台(TCMSP)、中医药百科全书数据库(ETCM)检索泽泻汤合丹参饮中5味中药的有效成分及其作用靶点,并构建泽泻汤合丹参饮药物-成分-靶点网络图,分别在人类基因综合数据库(GeneCards)、在0+线人类孟德尔遗传数据库(OMIM)检索获取AS疾病相关靶点,将交集靶点提交至String数据库构建蛋白质-蛋白质相互作用(PPI)网络,利用Metascape数据库进行基因本体(GO)和京都基因和基因组百科全书(KEGG)富集分析;采用高脂饮食喂养法复制AS大鼠模型,造模时给予泽泻汤合丹参饮低剂量、中剂量、高剂量(6.3、12.6、25.2 g/kg)干预,验证网络药理学所得结论。结果:通过数据挖掘最终获得59个与泽泻汤合丹参饮相关的靶点,1 187个AS相关靶基因,对接获得63个交集靶点,通过构建PPI核心网络,显示关键靶基因62个,包括蛋白激酶B1(AKT1)、肿瘤坏死因子(TNF)、白细胞介素-6(IL-6)等,KEGG富集分析结果显示泽泻汤合丹参饮治疗AS关键信号通路为磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(AKT)信号通路等。动物实验证实,与模型组比较,泽泻汤合丹参饮可明显降低AS大鼠的血脂、炎症介质IL-6、C反应蛋白(CRP)含量,下调主动脉组织p-PI3K、p-AKT蛋白的表达,减轻主动脉内皮脂质损伤。结论:泽泻汤合丹参饮可能通过调节脂质代谢、抑制炎症反应、调节PI3K/AKT信号通路等途径,达到防治AS的目的。

    Abstract:

    To explore the mechanism of Zexie Decoction combined with Danshen Decoction in the treatment of atherosclerosis(AS) using network pharmacology and animal experiments.Methods:The effective components and target genes of the five drugs in Zexie Decoction combin0ed with Danshen Decoction were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP) and the Encyclopedia of Traditional Chinese Medicine(ETCM).A drug-component-target network diagram was constructed.Relevant AS disease targets were obtained from the GeneCards database and the Online Mendelian Inheritance in Man(OMIM) database,and the intersection targets were submitted to the STRING database to construct a protein-protein interaction(PPI) network.Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG) enrichment analyses were conducted using the Metascape database.The high-fat diet-induced AS rat model was established,and Zexie Decoction combined with Danshen Decoction was administered at low,medium,and high doses(6.3,12.6,25.2 g/kg) to verify the conclusions derived from network pharmacology.Results:Data mining identified 59 targets related to Zexie Decoction combined with Danshen Decoction and 1 187 AS-related target genes.Molecular docking revealed 63 intersecting targets.The core PPI network identified 62 key targets,including protein kinase B(AKT1),tumor necrosis factor(TNF),and interleukin 6(IL-6).KEGG enrichment analysis indicated that the key signaling pathway for treating AS with Zexie Decoction combined with Danshen Decoction was the phosphoinositide 3-kinase(PI3K)/AKT signaling pathway.Animal experiments confirmed that,compared to the model group,Zexie Decoction combined with Danshen Decoction significantly reduced blood lipids,inflammatory mediators such as IL-6 and C-reactive protein(CRP),downregulated the expression of p-PI3K and p-AKT proteins in aortic tissue,and alleviated lipid-induced endothelial damage in the aorta.Conclusion:Zexie Decoction combined with Danshen Decoction may prevent and treat AS by regulating lipid metabolism,inhibiting inflammation,and modulating the PI3K/AKT signaling pathway.

    参考文献
    相似文献
    引证文献
引用本文

李思潼,顾亚茹,于泽鹤,肖依,刘佳,储心乔,张一昕.泽泻汤合丹参饮治疗动脉粥样硬化的药理实验及分子生物学作用机制[J].世界中医药,2025,(01).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-09-01
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-30
  • 出版日期:
文章二维码